6-46637857-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_016593.5(CYP39A1):​c.610G>A​(p.Gly204Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000233 in 1,459,988 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000023 ( 0 hom. )

Consequence

CYP39A1
NM_016593.5 missense

Scores

2
10
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.41

Publications

0 publications found
Variant links:
Genes affected
CYP39A1 (HGNC:17449): (cytochrome P450 family 39 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum protein is involved in the conversion of cholesterol to bile acids. Its substrates include the oxysterols 25-hydroxycholesterol, 27-hydroxycholesterol and 24-hydroxycholesterol. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP39A1NM_016593.5 linkc.610G>A p.Gly204Arg missense_variant Exon 4 of 12 ENST00000275016.3 NP_057677.2 Q9NYL5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP39A1ENST00000275016.3 linkc.610G>A p.Gly204Arg missense_variant Exon 4 of 12 1 NM_016593.5 ENSP00000275016.2 Q9NYL5
CYP39A1ENST00000619708.4 linkc.94G>A p.Gly32Arg missense_variant Exon 3 of 11 1 ENSP00000477769.1 A0A087WTD2
CYP39A1ENST00000480804.1 linkn.29G>A non_coding_transcript_exon_variant Exon 1 of 5 5

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000401
AC:
1
AN:
249416
AF XY:
0.00000742
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000294
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000233
AC:
34
AN:
1459988
Hom.:
0
Cov.:
31
AF XY:
0.0000193
AC XY:
14
AN XY:
726196
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33338
American (AMR)
AF:
0.0000226
AC:
1
AN:
44286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26102
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39638
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85680
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53390
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5644
European-Non Finnish (NFE)
AF:
0.0000288
AC:
32
AN:
1111608
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 15, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.610G>A (p.G204R) alteration is located in exon 4 (coding exon 4) of the CYP39A1 gene. This alteration results from a G to A substitution at nucleotide position 610, causing the glycine (G) at amino acid position 204 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.75
BayesDel_addAF
Uncertain
0.075
D
BayesDel_noAF
Uncertain
-0.050
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.084
.;T
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Benign
0.73
D
LIST_S2
Uncertain
0.95
D;D
M_CAP
Benign
0.027
D
MetaRNN
Uncertain
0.64
D;D
MetaSVM
Benign
-0.64
T
MutationAssessor
Uncertain
2.7
.;M
PhyloP100
5.4
PrimateAI
Benign
0.47
T
PROVEAN
Uncertain
-3.4
.;D
REVEL
Uncertain
0.41
Sift
Benign
0.15
.;T
Sift4G
Uncertain
0.0050
D;D
Polyphen
1.0
.;D
Vest4
0.64
MutPred
0.64
.;Gain of methylation at G204 (P = 0.0431);
MVP
0.77
MPC
0.28
ClinPred
0.96
D
GERP RS
5.7
Varity_R
0.44
gMVP
0.72
Mutation Taster
=67/33
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1430320580; hg19: chr6-46605594; API